Better in vitro models with human iPSC-derived cells
Axol Bioscience is the first choice for high-quality, functionally relevant human iPSC-derived cells. Powering advanced, more human-relevant in vitro disease models.
Looking to use high-quality iPSC-derived cells in your in vitro projects? Take a look at Axol’s new axoCellsTM Catalog to explore their range of functional iPSC-derived cells for research and drug discovery.
Axol Bioscience is the leading manufacturer of functional iPSC-derived cells and provider of outsourced services to support drug discovery programs.
With over a decade of hard-earned stem cell experience, Axol has become a valued partner to the BioPharma community who look to employ more human-relevant iPSC powered in vitro models for their research. They deliver a complete end-to-end offering from iPSC generation, cell manufacturing, technical services including complex gene-editing, banking, reprogramming and differentiation through to outsourced model building, assay development and compound testing.
Axol are at the forefront of iPSC-based quality systems, cell characterization and functionality testing, and advanced co-culture model building. They operate according to their values of performance, accountability, transparency, acting with integrity, diversity & inclusivity, and collaboration.
Axol operates in five key market areas:
To find out more, take a look at their 2025 axoCellsTM Catalog! This is a comprehensive document to highlight their axoCellsTM range, comprising of human iPSC-derived cells optimized for use in advanced in vitro model systems for research, toxicity screening and drug discovery.
Axol have a simple aim: unlocking the benefits of iPSC technology for your research. Their focus on quality, functional performance and consistency has led them to becoming the first choice for iPSC-derived cells in the Neuroscience, Pain & Sensation, Ophthalmology, Dermatology, and Cardiovascular spaces.
Check out their catalog here: 2025 axoCells iPSC Catalog | Axol Bioscience.
We gladly support you by keeping you updated on our latest products and the developments around our services.